199 related articles for article (PubMed ID: 32956692)
1. Optimizations of a novel fluorescence polarization-based high-throughput screening assay for β-catenin/LEF1 interaction inhibitors.
Chen Y; Fu Z; Li D; Yue Y; Liu X
Anal Biochem; 2021 Jan; 612():113966. PubMed ID: 32956692
[TBL] [Abstract][Full Text] [Related]
2. [Optimizations of an ELISA-like high-throughput screening assay for the discovery of β-catenin/TCF4 interaction antagonists].
Fu Z; Yan G; Zhu X; Liu X; Chen Y
Sheng Wu Gong Cheng Xue Bao; 2021 Aug; 37(8):2878-2889. PubMed ID: 34472305
[TBL] [Abstract][Full Text] [Related]
3. [Development of an ELISA-based high throughput screening method for novel anticancer agents targeting β-catenin/Lef1 interaction].
Chen Y; Niu X; Li Y; Liu X
Sheng Wu Gong Cheng Xue Bao; 2019 Apr; 35(4):707-717. PubMed ID: 31001956
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the interaction of BCL9 with beta-catenin and development of fluorescence polarization and surface plasmon resonance binding assays for this interaction.
Kawamoto SA; Thompson AD; Coleska A; Nikolovska-Coleska Z; Yi H; Wang S
Biochemistry; 2009 Oct; 48(40):9534-41. PubMed ID: 19715304
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel fluorescence polarization-based assay for studying the β-catenin/Tcf4 interaction.
Tian W; Xu Y; Han X; Duggineni S; Han X; Huang Z; An J
J Biomol Screen; 2012 Apr; 17(4):530-4. PubMed ID: 22127421
[TBL] [Abstract][Full Text] [Related]
6. Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1.
Kim GH; Fang XQ; Lim WJ; Park J; Kang TB; Kim JH; Lim JH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933177
[TBL] [Abstract][Full Text] [Related]
7. The osteogenic differentiation of human adipose-derived stem cells is regulated through the let-7i-3p/LEF1/β-catenin axis under cyclic strain.
Luo Y; Ge R; Wu H; Ding X; Song H; Ji H; Li M; Ma Y; Li S; Wang C; Du H
Stem Cell Res Ther; 2019 Nov; 10(1):339. PubMed ID: 31753039
[TBL] [Abstract][Full Text] [Related]
8. AlphaScreen selectivity assay for β-catenin/B-cell lymphoma 9 inhibitors.
Zhang M; Wisniewski JA; Ji H
Anal Biochem; 2015 Jan; 469():43-53. PubMed ID: 25312469
[TBL] [Abstract][Full Text] [Related]
9. Targeting the WNT/beta-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options.
Gehrke I; Gandhirajan RK; Kreuzer KA
Eur J Cancer; 2009 Nov; 45(16):2759-67. PubMed ID: 19729298
[TBL] [Abstract][Full Text] [Related]
10. SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.
Freihen V; Rönsch K; Mastroianni J; Frey P; Rose K; Boerries M; Zeiser R; Busch H; Hecht A
Int J Cancer; 2020 Apr; 146(8):2229-2242. PubMed ID: 31463973
[TBL] [Abstract][Full Text] [Related]
11. PARsylated transcription factor EB (TFEB) regulates the expression of a subset of Wnt target genes by forming a complex with β-catenin-TCF/LEF1.
Kim S; Song G; Lee T; Kim M; Kim J; Kwon H; Kim J; Jeong W; Lee U; Na C; Kang S; Kim W; Seong JK; Jho EH
Cell Death Differ; 2021 Sep; 28(9):2555-2570. PubMed ID: 33753903
[TBL] [Abstract][Full Text] [Related]
12. OTUD7B Activates Wnt Signaling Pathway through the Interaction with LEF1.
Lee Y; Piao HL; Kim J
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371581
[TBL] [Abstract][Full Text] [Related]
13. Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.
Gandhirajan RK; Staib PA; Minke K; Gehrke I; Plickert G; Schlösser A; Schmitt EK; Hallek M; Kreuzer KA
Neoplasia; 2010 Apr; 12(4):326-35. PubMed ID: 20360943
[TBL] [Abstract][Full Text] [Related]
14. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
15. Discovery of chemical probes that suppress Wnt/β-catenin signaling through high-throughput screening.
Yamaguchi K; Nagatoishi S; Tsumoto K; Furukawa Y
Cancer Sci; 2020 Mar; 111(3):783-794. PubMed ID: 31912579
[TBL] [Abstract][Full Text] [Related]
16. Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.
Tan HY; Wang N; Li S; Hong M; Guo W; Man K; Cheng CS; Chen Z; Feng Y
Cell Physiol Biochem; 2018; 47(5):1819-1834. PubMed ID: 29953980
[TBL] [Abstract][Full Text] [Related]
17. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
18. β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway.
Zhou AD; Diao LT; Xu H; Xiao ZD; Li JH; Zhou H; Qu LH
Oncogene; 2012 Jun; 31(24):2968-78. PubMed ID: 22020335
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin/LEF1 activated enamelin expression in ameloblast-like cells.
Tian H; Lv P; Ma K; Zhou C; Gao X
Biochem Biophys Res Commun; 2010 Jul; 398(3):519-24. PubMed ID: 20599763
[TBL] [Abstract][Full Text] [Related]
20. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter.
Kahler RA; Westendorf JJ
J Biol Chem; 2003 Apr; 278(14):11937-44. PubMed ID: 12551949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
